Archives: Speakers

With a distinguished career in the clinical trial industry, Stacey Curelop brings a wealth of expertise in effectively managing clinical programs. Over the past decade, Stacey has successfully planned and executed more than 10 clinical trials, mainly in women’s health and infectious diseases, ensuring patient safety and maintaining data integrity, consistently delivering results within budget, scope, and schedule.

Recently, Stacey concurrently directed three Phase III trials, including two global studies spanning 11 countries. Navigating the complexities of these projects with remarkable precision culminated in FDA approval in 2022—an achievement notably realized amid the challenges posed by the COVID-19 pandemic.

In her role, Stacey has effective oversight of large global teams, expertly coordinating efforts across multiple vendors in clinical monitoring, data management, statistics, safety, medical writing, and central labs. Her comprehensive knowledge of FDA regulations, ICH/GCP guidelines, and professional expertise in Pharmacovigilance, has been instrumental in driving project success.

Stacey’s impressive track record and ability to navigate the intricacies of clinical trials make her a compelling speaker and a valuable resource for insights into the ever-evolving landscape of clinical research.